Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences
Top Cited Papers
- 12 August 2010
- journal article
- Published by American Society of Hematology in Blood
- Vol. 116 (6), 878-885
- https://doi.org/10.1182/blood-2010-02-261891
Abstract
Patients with liver disease frequently acquire a complex disorder of hemostasis secondary to their disease. Routine laboratory tests such as the prothrombin time and the platelet count are frequently abnormal and point to a hypocoagulable state. With more sophisticated laboratory tests it has been shown that patients with liver disease may be in hemostatic balance as a result of concomitant changes in both pro- and antihemostatic pathways. Clinically, this rebalanced hemostatic system is reflected by the large proportion of patients with liver disease who can undergo major surgery without any requirement for blood product transfusion. However, the hemostatic balance in the patient with liver disease is relatively unstable as evidenced by the occurrence of both bleeding and thrombotic complications in a significant proportion of patients. Although it is still common practice to prophylactically correct hemostatic abnormalities in patients with liver disease before invasive procedures by administration of blood products guided by the prothrombin time and platelet count, we believe that this policy is not evidence-based. In this article, we will provide arguments against the traditional concept that patients with liver failure have a hemostasis-related bleeding tendency. Consequences of these new insights for hemostatic management will be discussed.Keywords
This publication has 95 references indexed in Scilit:
- The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood ServiceTransfusion Medicine, 2009
- Review article: blood platelet number and function in chronic liver disease and cirrhosisAlimentary Pharmacology & Therapeutics, 2008
- Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current managementHepatology, 2006
- Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacityHepatology, 2006
- Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation testsHepatology, 2005
- Haemostatic abnormalities in patients with liver diseaseJournal of Hepatology, 2002
- Endothelial dysfunction in cirrhosis and portal hypertensionPharmacology & Therapeutics, 2001
- Disseminated intravascular coagulation in liver cirrhosisJournal of Hepatology, 1992
- A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosisGastroenterology, 1991
- Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia.JCI Insight, 1966